4.75
price up icon2.37%   0.11
after-market アフターアワーズ: 4.90 0.15 +3.16%
loading
前日終値:
$4.64
開ける:
$4.62
24時間の取引高:
3.06M
Relative Volume:
1.49
時価総額:
$795.07M
収益:
$25.55M
当期純損益:
$-341.97M
株価収益率:
-1.7658
EPS:
-2.69
ネットキャッシュフロー:
$-304.44M
1週間 パフォーマンス:
-6.95%
1か月 パフォーマンス:
-28.68%
6か月 パフォーマンス:
-36.92%
1年 パフォーマンス:
-41.14%
1日の値動き範囲:
Value
$4.62
$4.90
1週間の範囲:
Value
$4.48
$5.185
52週間の値動き範囲:
Value
$4.48
$12.14

Relay Therapeutics Inc Stock (RLAY) Company Profile

Name
名前
Relay Therapeutics Inc
Name
セクター
Healthcare (1195)
Name
電話
617-370-8837
Name
住所
399 BINNEY STREET, CAMBRIDGE
Name
職員
294
Name
Twitter
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
RLAY's Discussions on Twitter

RLAY を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
RLAY 4.75 795.07M 25.55M -341.97M -304.44M -2.69
VRTX 450.97 116.14B 10.63B -479.80M -1.35B 13.33
REGN 738.00 81.10B 13.85B 4.65B 3.32B 35.06
ARGX 605.92 36.23B 1.86B -40.29M -1.28B -4.16
ALNY 244.89 31.59B 2.09B -332.26M 16.06M -4.14
BNTX 113.13 27.12B 3.30B -501.07M 1.03B 11.54

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-04-20 アップグレード Jefferies Underperform → Hold
2023-04-19 アップグレード Raymond James Outperform → Strong Buy
2023-04-13 開始されました Raymond James Outperform
2023-02-03 開始されました Oppenheimer Outperform
2022-09-30 開始されました Barclays Equal Weight
2022-09-02 開始されました Stifel Buy
2022-06-06 開始されました Jefferies Underperform
2022-02-01 開始されました Berenberg Buy
2021-07-21 開始されました BofA Securities Buy
2020-12-15 繰り返されました H.C. Wainwright Buy
2020-12-08 開始されました JMP Securities Mkt Outperform
2020-11-05 開始されました H.C. Wainwright Buy
2020-08-10 開始されました Cowen Outperform
2020-08-10 開始されました Goldman Buy
2020-08-10 開始されました Guggenheim Buy
2020-08-10 開始されました JP Morgan Neutral
すべてを表示

Relay Therapeutics Inc (RLAY) 最新ニュース

pulisher
Nov 22, 2024

Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 22, 2024
pulisher
Nov 21, 2024

Layoff Tracker: J&J, Merck Trimming Workforces in China - BioSpace

Nov 21, 2024
pulisher
Nov 20, 2024

Down -27.93% in 4 Weeks, Here's Why Relay Therapeutics (RLAY) Looks Ripe for a Turnaround - Yahoo Finance

Nov 20, 2024
pulisher
Nov 19, 2024

Down -23.95% in 4 Weeks, Here's Why Relay Therapeutics (RLAY) Looks Ripe for a Turnaround - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

First Turn Management LLC Buys New Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - MarketBeat

Nov 19, 2024
pulisher
Nov 17, 2024

Relay Therapeutics (NASDAQ:RLAY) Trading Down 4.8% – Here’s What Happened - Defense World

Nov 17, 2024
pulisher
Nov 15, 2024

Relay Therapeutics (NASDAQ:RLAY) Stock Price Down 4.8%Time to Sell? - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

(RLAY) Trading Report - Stock Traders Daily

Nov 14, 2024
pulisher
Nov 14, 2024

Relay Therapeutics stock hits 52-week low at $5.59 - Investing.com India

Nov 14, 2024
pulisher
Nov 14, 2024

Relay Therapeutics stock hits 52-week low at $5.59 By Investing.com - Investing.com UK

Nov 14, 2024
pulisher
Nov 14, 2024

Analyzing Valneva (NASDAQ:VALN) and Relay Therapeutics (NASDAQ:RLAY) - Defense World

Nov 14, 2024
pulisher
Nov 14, 2024

NKGen Biotech (NYSE:NKGN) versus Relay Therapeutics (NASDAQ:RLAY) Financial Contrast - Defense World

Nov 14, 2024
pulisher
Nov 13, 2024

Relay Therapeutics' SWOT analysis: PI3K inhibitor progress fuels stock potential - Investing.com

Nov 13, 2024
pulisher
Nov 12, 2024

HC Wainwright Forecasts Strong Price Appreciation for Relay Therapeutics (NASDAQ:RLAY) Stock - Defense World

Nov 12, 2024
pulisher
Nov 11, 2024

Relay Therapeutics Gives Business Update - substack.com

Nov 11, 2024
pulisher
Nov 11, 2024

Research Analysts Offer Predictions for RLAY FY2024 Earnings - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

FY2024 Earnings Estimate for RLAY Issued By Leerink Partnrs - Defense World

Nov 11, 2024
pulisher
Nov 09, 2024

Relay Therapeutics (NASDAQ:RLAY) Given New $20.00 Price Target at HC Wainwright - MarketBeat

Nov 09, 2024
pulisher
Nov 07, 2024

Relay Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

RLAYRelay Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

Relay Therapeutics Reports Q3 2024 Results and Advances - TipRanks

Nov 07, 2024
pulisher
Nov 06, 2024

Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Relay Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024
pulisher
Nov 04, 2024

Where are the Opportunities in (RLAY) - Stock Traders Daily

Nov 04, 2024
pulisher
Oct 31, 2024

Relay Therapeutics (RLAY) to Release Earnings on Wednesday - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Relay Therapeutics stock hits 52-week low at $5.7 amid market shifts - Investing.com Australia

Oct 31, 2024
pulisher
Oct 30, 2024

Relay Therapeutics stock hits 52-week low at $5.7 amid market shifts By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024 - The Manila Times

Oct 30, 2024
pulisher
Oct 30, 2024

Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, - EIN News

Oct 30, 2024
pulisher
Oct 29, 2024

Intrahepatic Cholangiocarcinoma Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Key Companies involved by DelveInsight | Xencor, Relay Therapeutics, Kinnate Biopharma, Forma Therapy - Barchart

Oct 29, 2024
pulisher
Oct 28, 2024

Institutional owners may consider drastic measures as Relay Therapeutics, Inc.'s (NASDAQ:RLAY) recent US$67m drop adds to long-term losses - Yahoo Finance

Oct 28, 2024
pulisher
Oct 28, 2024

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Oct 28, 2024
pulisher
Oct 25, 2024

Several Relay Therapeutics Insiders Sell Shares Sending Potential Negative Signal - Simply Wall St

Oct 25, 2024
pulisher
Oct 25, 2024

Relay Therapeutics' SWOT analysis: oncology innovator's stock faces pivotal phase - Investing.com Canada

Oct 25, 2024
pulisher
Oct 24, 2024

Relay Therapeutics' SWOT analysis: oncology innovator's stock faces pivotal phase By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 16, 2024

Financial Snapshot: Analyzing Relay Therapeutics Inc (RLAY)’s Key Ratio Metrics - The Dwinnex

Oct 16, 2024
pulisher
Oct 15, 2024

Relay Therapeutics, Inc. (NASDAQ:RLAY) Short Interest Update - MarketBeat

Oct 15, 2024
pulisher
Oct 14, 2024

How did Relay Therapeutics Inc (RLAY) fare last session? - US Post News

Oct 14, 2024
pulisher
Oct 14, 2024

Relay Therapeutics (NASDAQ:RLAY) Receives Buy Rating from HC Wainwright - MarketBeat

Oct 14, 2024

Relay Therapeutics Inc (RLAY) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Relay Therapeutics Inc (RLAY) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Catinazzo Thomas
Chief Financial Officer
Oct 28 '24
Sale
6.06
6,802
41,220
306,391
Catinazzo Thomas
Chief Financial Officer
Oct 29 '24
Sale
5.95
2,300
13,685
304,091
Bergstrom Donald A
President, R&D
Oct 28 '24
Sale
6.06
2,688
16,289
520,745
Adams Brian
Chief Legal Officer
Oct 28 '24
Sale
6.06
1,632
9,890
321,907
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
大文字化:     |  ボリューム (24 時間):